The latest news from Van der Laan & Science.

We were awarded AtheroNETH: finding biomarkers and druggable targets for personalized primary prevention.
Unraveling the Heart of Type 1 Diabetes: on our U01 grant to study the immune-link between type 1 diabetes, type 2 diabetes and cardiovascular disease.
We were awarded this project which aims to develop a data-driven approach to AI-based phenotyping of atherosclerosis. We aim to deep-phenotype plaques and discover novel biomarkers for patient stratification.
Together with the Miller lab we will execute an integrative single-cell meta-analysis for atherosclerosis funded by the Chan Zuckerberg Initiative.
We collaborated with the Miller Lab to create PlaqView: a portal to plaque single-cell data.

Sander W. van der Laan 12/1/22 Sander W. van der Laan 12/1/22

4th General Assembly of Horizon 2020 ‘TO_AITION’

On the General Assembly of TO_AITION in Utrecht to discuss the progress, results and next steps for our project. As partners affiliated with the UMC Utrecht it is a pleasure to be this year’s host in our hometown.

Sander W. van der Laan 10/17/21 Sander W. van der Laan 10/17/21

MetaPlaq

MetaPlaq: Integrative Single-Cell Meta-Analysis for Atherosclerosis.

Sander W. van der Laan 3/31/21 Sander W. van der Laan 3/31/21

PlaqView

PlaqView: a portal to plaque single-cell data.

Sander W. van der Laan 12/26/19 Sander W. van der Laan 12/26/19

DEEP-ENIGMA

DEEP-ENIGMA: a DEEP nEural Network for Image seGMentation to classify and quantify Atherosclerotic disease based on high-resolution scanned histological slides.